Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- · 21d
- Not stated
- Not stated
- Mar 18, 2026
Official announcement on nih_guide+grants_gov · opens the funder's page. Always confirm dates there.
Summary
NOFO Research Objectives This NOFO supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials. Clinical trials supported by this NOFO include Phase II and above clinical trials that will enroll participants from two or more recruitment sites. […]
Other topics in this solicitation
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)
$400k
Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- All 3 review criteria reviewers score this against, extracted from this announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k